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in the emergency department and in the primary care setting
[1]. In the United States, approximately 300,000 patients are
admitted to the hospital annually [2]. Upper GI hemorrhage
has an annual incidence that ranges from 40-150 episodes
per 100,000 persons [3] compared with lower GI hemor-
rhage, which is less common, with an annual incidence that
ranges from 20-27 episodes per 100,000 persons. The
mortality rate from GI bleeding in the presence of hemo-
dynamic instability may reach 40%, which makes accurate
and prompt diagnosis of the source of bleeding crucial [4]. In
more stable patients, the mortality is lower, ranging from
3.6%-19% [3,5,6].
In up to 75% of cases, bleeding will cease spontaneously,
but recurrence may occur in 25%, which emphasizes the
need for accurate diagnosis and effective therapy, preferably
in the acute setting [2,6]. Endoscopy is considered the
primary diagnostic and therapeutic modality in the setting of
GI hemorrhage. Nevertheless, due to the large number of
potential etiologies, a high prevalence of obscure bleeding
sources, and the long length of the GI tract, with many
segments inaccessible to endoscopy, imaging continues to
play an important role in the diagnosis of GI hemorrhage [7].
Therefore, it is important that all diagnostic and interven-
tional radiologists fully understand the role of imaging and
endovascular treatment of GI hemorrhage. In this article, we* Address for correspondence: Jeffrey D. Jaskolka, MD, Department of
Medical Imaging, Mount Sinai Hospital, 600 University Avenue, Room 564,
Toronto, Ontario M5G 1X5, Canada.
E-mail address: jjaskolka@mtsinai.on.ca (J. D. Jaskolka).
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http://dx.doi.org/10.1016/j.carj.2012.08.001briefly discuss the clinical presentation, major causes of GI
tract hemorrhage, and the diagnosis and management from
a clinical perspective. We will primarily focus on the
radiologic diagnosis and management with a special focus on
the emerging role of computed tomographic angiography
(CTA) as well the most recent advances in endovascular
treatment.Clinical Presentation and Major Causes of Upper and
Lower GI Tract Hemorrhage
By definition, upper GI bleeding originates proximal to the
ligament of Treitz, and lower GI imaging originates beyond
the ligament of Treitz. Upper GI bleeding may originate in the
esophagus, stomach, and duodenum, and carries a mortality
rate of approximately 10% [5]. Common causes of upper GI
bleeding are peptic ulcer disease, variceal bleeding,
Mallory-Weiss tear, vascular lesions, and neoplasms (Table 1)
[2]. Lower GI bleeding may originate in the small bowel,
colon, or rectum [8] and carries a mortality rate of 3.6% [9].
Lower GI bleeding is more common in elderly patients and is
200 times more likely to affect an 80-year-old patient than
a 20-year-old patient [2]. Common causes of lower GI
bleeding are diverticular disease, angiodysplasia, neoplasms,
colitis, and benign anorectal lesions such as hemorrhoids, anal
fissures, and rectal ulcers (Table 2) [2].
Upper GI bleeding usually presents with hematemesis
(vomiting of blood or ‘‘coffee ground’’-like material) and/or
melena (black, tarry stools). Lower GI bleeding classically
presents with hematochezia (passage of maroon or bright redll rights reserved.
Table 1
Common causes of upper gastrointestinal hemorrhagea
Peptic ulcer disease (55%)
Infections (Helicobacter pylori, viral)
Drug induced
Stress induced
Zollinger Ellison syndrome
Other causes of esophagitis and/or gastritis and/or duodenitis
Portal hypertension
Varices (14%)
Portal gastropathy
Neoplasms (4%)
Traumatic or iatrogenic
Mallory-Weiss tear (5%)
Foreign body ingestions
After surgery
After biopsy and/or polypectomy
Vascular
Arteriovenous malformations (6%)
Dieulafoy lesion (1%)
Aortoenteric fistula
Pancreaticobiliary
a The numbers in parentheses indicate the frequencies of the most common
etiologies for upper gastrointestinal hemorrhage.
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not free from exceptions, because bleeding from the right
colon (or the small intestine) can present with melena, and
massive upper GI bleeding can present with hematochezia
[10e12]. The use of nasogastric-tube insertion and gastric
lavage in all patients with suspected upper GI bleeding is
controversial. Although a lavage that yields blood or ‘‘coffee
ground’’-like material confirms the diagnosis, lavage may not
be positive if bleeding is no longer active or if the source of
bleeding is beyond a closed pylorus. Studies of the use of
nasogastric-tube insertion have failed to demonstrate a benefit
with regard to clinical outcomes [13,14]. In all patients who
present with clinically significant GI hemorrhage, initial
management is aimed at resuscitation of the patient, followed
by rapid diagnosis, and, if possible, treatment.
Diagnosis
Options for the diagnosis of GI hemorrhage include
endoscopy and/or colonoscopy, nuclear scintigraphy, CTA,
and catheter angiography. The relative importance of each ofTable 2
Common causes of lower gastrointestinal hemorrhagea
Diverticulosis (15%-55%)
Angiodysplasia (3%-37%)
Neoplasm (3%-11%)
Polyp
Carcinoma
Iatrogenic (0%-13%)
After biopsy and/or polypectomy
Ischemia (6%-18%)
Infection
Inflammatory bowel disease
Benign anorectal lesions
a The numbers in parentheses indicate the frequencies of the most common
etiologies for upper gastrointestinal hemorrhage.these modalities is different for upper- and lower GI
bleeding, and will be reviewed in turn.Endoscopy and/or ColonoscopyIn patients with upper GI bleeding, endoscopy is consid-
ered the criterion standard for diagnosis. It has the advantage
of being both a diagnostic and therapeutic modality. Although
somewhat invasive, it is generally considered safe to perform
in patients with upper GI bleeding, including those with
medical comorbidities, severe hemorrhage, and altered
coagulation. The reported sensitivity and specificity of
endoscopy for upper gastroduodenal bleeding are 92%-98%
and 30%-100%, respectively, and a repeated endoscopy may
further increase the diagnostic yield when performed by an
experienced operator. Endoscopy has the ability to identify
active bleeding but may also identify etiology and the site of
hemorrhage in those patients who have ceased bleeding.
These patients can potentially be treated despite a lack of
ongoing hemorrhage, although the value of this approach is
controversial. In cases in which bleeding can be identified but
not treated endoscopically, a metallic clip can be placed to
guide angiography for either selective or empiric emboliza-
tion (Figure 1). In the setting of upper GI bleeding, imaging is
reserved for nondiagnostic endoscopy in which a bleeding site
cannot be identified and/or treated, which may occur when
there is very rapid bleeding and blood in the stomach obscures
the endoscopic visualization of the underlying source.
In lower GI hemorrhage, the diagnostic approach is some-
what more variable. The American College of Gastroenter-
ology has issued guidelines that suggest that colonoscopy
should be the first-line diagnostic modality for evaluation and
treatment of lower GI bleeding [15]. However, there are several
limitations to colonoscopy in the setting of acute lower GI
hemorrhage, including the potential for inadequate bowel
preparation, the inability to evaluate most of the small bowel,
risks of sedation in hemodynamically unstable patients, a low
prevalence of stigmata of hemorrhage, and a potential lack of
availability of an appropriate team for performance of the
procedure [16]. Although colonoscopy can determine the
etiology of hemorrhage in 91% of patients overall [17], this
number decreases in patients without adequate bowel prepa-
ration, and successful treatment may only be possible in as few
as 21% of patients in the acute setting [18]. The American
College of Radiology recommends colonoscopy as the initial
modality in hemodynamically stable patients (in whom there is
time to undergo colonic preparation) and angiography in those
who are hemodynamically unstablewithmassive bleeding [19].Nuclear ScintigraphyGI hemorrhage has long been diagnosed with scinti-
graphic techniques. In current practice, the most commonly
used agent is technetium 99melabeled red blood cells.
Active bleeding can generally be detected at rates of 0.3 mL/
min, and some investigators believe that rates as low as 0.1
mL/min can be detected [20]. Nuclear scintigraphy has the
Figure 1. Postanastamotic hemorrhage after Bilroth 2 gastrojejunostomy treated with embolization. Endoscopic treatment failed twice prior to arteriography.
(A) Superior mesenteric artery (SMA) arteriogram showing hemorrhage from first jejunal artery, immediately adjacent to endoscopically placed clip (arrow).
(B) Initial subselective arteriogram of first jejunal artery showing absence of extravasation. (C) Subsequent subselective arteriogram of first jejunal artery,
showing active extravasation. (D) SMA arteriogram after embolization with three 2  3.3-mm microcoils showing no further hemorrhage.
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image over long periods of time and, therefore, potentially
detect intermittent bleeding. However, the spatial resolution
of scintigraphy is lower than that of other modalities, and the
precise etiology of hemorrhage cannot be determined. In
addition, intervention is not possible with this modality.
Some investigators suggest that scintigraphy can be used as
a screening test for angiography with positive red blood cell
scans, which increases the likelihood of finding active
extravasation on angiography and, therefore, predicting the
likelihood of finding a treatable lesion [21,22]. When posi-
tive, scintigraphy is useful for localizing bleeding for endo-
scopic, surgical, or endovascular therapy (Figure 2). Nuclear
scintigraphy is likely most useful for evaluation of subacute
or chronic hemorrhage in centres where endoscopy,
computed tomography (CT), and/or CTA are available.CTAOver the past decade, there has been a growing interest in
the use of CTA for evaluation of patients with both upper- and
lower GI hemorrhage [23e32]. These studies all support an
emerging role for CT in the diagnosis of GI hemorrhage,
which highlights the fact that CT is very accurate for deter-
mining the location and etiology of hemorrhage. These studies
are generally limited by their small numbers, heterogeneity in
imaging technique and patient populations, and also byselection bias. The most recent prospective study [32] studied
47 patients, with a reference standard of angiography,
endoscopy, surgery, or a combination of these and showed
sensitivity, specificity, positive predictive value, and negative
predictive value of 100%, 96%, 95%, and 100%, respectively.
Three meta-analyses have been performed with this
patient population. The most recent [33] used results from 6
prospective studies and 3 retrospective studies, which
incorporated a total of 198 patients. The pooled sensitivity
and specificity for diagnosis of GI hemorrhage were 89% and
85%, respectively. The area under the summary receiver
operator characteristics curve was 0.93, which indicates very
good diagnostic accuracy. The investigators conclude that
CT should be used as the first-line radiologic test for eval-
uation of patients with acute GI hemorrhage.
There are many potential advantages to performing CTA
for the diagnosis of GI hemorrhage. First, it is noninvasive
and more widely available than catheter angiography.
Second, it may be more sensitive than angiography for
detection of bleeding. In an animal model, it has been shown
that CTA can detect extravasation of blood at a rate as low as
0.3 mL/min, although more reliably at 0.5 mL/min [34],
which is lower than that reported for catheter angiography
[35,36] and similar to the rates of bleeding detectable by
scintigraphy [20]. A CT can also demonstrate evidence of
recent bleeding, for example, blood in the bowel lumen [24].
It can identify lesions such as neoplasms or vascular
Figure 2. Right colonic diverticular hemorrage with positive 99mTc-red blood cell (RBC) scan, confirmed on arteriography and subsequently embolized. (A)
Multiple frames from 99mTc-RBC scan showing abnormal activity in right lower quadrant (arrows), which progressively increases over time and has appearance
of the cecum in the later frames. (B) Superior mesenteric artery (SMA) arteriogram showing active extravasation in the right lower quadrant (arrow) with
a shape suggestive of a diverticulum. (C) SMA arteriogram after selective embolization with two 2  20-mm microcoils (arrow) shows no further extravasation.
Table 3
Suggested computed tomography protocol for evaluation of acute gastroin-
testinal hemorrhage
Large-bore intravenous catheter in antecubital fossa if possible
120 kVp and 240 mAs for all phases
No enteric contrast
May consider oral water if neoplasm or vascular
malformation is suspected
Noncontrast
5-mm slice thickness through entire abdomen and pelvis
Consider a low-dose technique
Arterial phase
100-150 mL of high-density, nonionic, iodinated contrast
Power injection at a rate of 4-5 mL/s
A normal saline solution bolus chase of 20 mL at the
same rate as the contrast injection
Initiate the scan when attenuation of aortic blood is 150 HU
1-mm slice thickness through the entire abdomen and pelvis
Coronal and sagittal reformations
Consider 5e10-mm-thick coronal maximum intensity projection
reconstructions
Venous phase
70 s after initial scan
5-mm slice thickness through entire abdomen and pelvis
Consider coronal and sagittal reformations 3e5-mm thick
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when they are not actively bleeding. It has also been
proposed that performing CTA before conventional angiog-
raphy is useful for procedure planning and may decrease
procedure time, radiation dose, and contrast volumes during
embolization [37]. CT may also detect some less common
arterial sources of hemorrhage such as hepatic or pancreatic
branches or the internal iliac arteries.
Avariety of CTA techniques have been used for evaluation
of GI bleeding, including intra-arterial CTA [23], single-
detector CT [23,24], and multidetector CT with up to 64
detectors [32,38]. Two studies have specifically addressed the
number of phases needed for evaluation. Results of one of
these studies suggested no added value of arterial and venous
phase scanning after contrast injection compared with a single
arterial or venous phase [39], which is in contrast to an animal
model in which it was shown that both phases are necessary to
obtain maximum sensitivity and specificity [40].
Most investigators recommend the use of triphasic tech-
nique [41,42], which includes a precontrast study, a CTA,
and a venous phase scan (Table 3). The noncontrast phase is
considered necessary to prevent a false-positive diagnosis
from preexisting density in the bowel, such as from suture
material, surgical clips, prior administration of positive
enteric contrast, ingested pills, and so forth. Arterial-phase
imaging with high-density contrast and thin-section acqui-
sition can detect extravasation of contrast and also provideangiogram-like images for directing embolization. It can also
increase conspicuity of vascular tufts, highly vascularized
masses, and early draining veins. Density of intraluminal
contrast >90 HU is considered diagnostic of active
Figure 3. Spontaneous cessation of bleeding after computed tomography (CT) angiography positive for diverticular hemorrhage. The patient improved
clinically and has had no evidence of recurrent hemorrhage at 6-month follow up. (A) Axial image from arterial phase CT showing active jet-like arterial
enhancement (arrow) in ascending colon at site of diverticulum. (B) Axial image from venous phase of CT shows progressive increasing intraluminal
enhancement (arrow). (C) Superior mesenteric artery arteriogram showing lack of active extravsation. (D) Subselective right colic arteriogram confirming lack
of extravasation.
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like, swirled, ellipsoid, or pooled [43]. The venous phase is
considered useful for evaluation of progressive contrast
extravasation as well as some of etiologies of hemorrhage,
such as neoplasms or polyps. Some investigators considered
bowel-wall thickening, perienteric stranding, and bowel-wall
enhancement as indicators of a location of hemorrhage.
Positive oral contrast should not be given because it may
obscure the density from extravasated contrast. There is
variability with regard to administration of negative oral
contrast, with some investigators advocating the use of oral
water [44] and others suggesting that oral contrast is
unnecessary [34] because it may dilute extravasated contrast
and decrease sensitivity for detection of hemorrhage [7]. At
present, the triphasic technique is recommended for optimal
sensitivity and specificity because the radiation dose is
a lesser concern in the setting of severe GI bleeding, which
may be life threatening. Interpretation of the CT study is
aided by use of multiplanar reformats and maximum inten-
sity projection images [42,45]. Active bleeding is required
for a positive CT. Detection rates are better in patients with
more severe bleeding, that is, in those with massive bleeding
(>4 units in 24 hours), hemoglobin level decrease of more
than 20 g/dL, or systolic blood pressure <90 mm Hg.
Although most investigators advocate the use of endos-
copy as the initial diagnostic test [15,19], especially for
upper GI bleeding, several investigators recommend CTA
instead of catheter angiography as the next step in evaluationof patients with negative endoscopy, and some investigators
suggest the use of CT before colonoscopy in the initial
evaluation of patients with lower GI hemorrhage. It is clear
from the literature that CTA is a potentially useful tool in the
diagnosis of GI bleeding. However, its exact role in the
evaluation of patients with GI hemorrhage requires further
study. A positive study is highly specific and should lead to
definitive therapy, usually catheter angiography, depending
on local institutional practice. However, the value of
a negative study in further triage of the patients needs to be
elucidated. Results of some studies indicate that a negative
CTA suggests spontaneous cessation of bleeding and carries
with it a low rate of rebleeding [30], and, therefore, a nega-
tive CTA obviates the need for catheter angiography
(Figure 3), which is supported by the high negative predi-
cative value in the study of Marti et al [32]. However, there is
a wide range of a negative predictive value, from 33%-100%,
in the other published studies. In 1 study [44], the investi-
gators assumed that a positive CT in the setting of a negative
angiogram constituted a true-positive study, whereas in most
other studies, these were considered as false-positive studies.
Although, strictly speaking, this is an incorrect approach
because other modalities are referred to as the criterion
standard, when one considers the intermittent nature of
bleeding and the possibly improved sensitivity to bleeding on
CT, this may have been a reasonable approach. In almost all
the published studies, there were some cases of positive CT
and negative angiography. Some of these had endoscopic
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should be the true criterion standard for a diagnosis of GI
hemorrhage. Even at surgery, a presumed bleeding lesion is
often removed, without conformation of active bleeding at
the time of laparotomy.
Based on the above discussion, a reasonable role for the use
of CT in evaluation of patients with GI bleeding is as follows:
1. In patients with mild GI bleeding, endoscopy or colo-
noscopy should be done first. If the endoscopy is nega-
tive, then a CT may be useful to detect bleeding and to
determine the etiology. If a bleeding source is found,
then it can be managed as determined by institutional
practice. In these patients with low acuity, it is likely
reasonable to assume that a negative study is truly
negative and that, regardless, this represents a group of
patients with good outcomes and that further urgent
therapy is unlikely to be needed.
2. In patients with massive GI hemorrhage but who are
stable, endoscopy should be done first in upper-GI
bleeding and, if it is negative, then a CT could be
considered before angiography. If the CT is negative for
active bleeding or an etiology of bleeding, then it mayFigure 4. Diverticular hemorrage from transverse post-right hemicolectomy, diagn
unenhanced CT image shows dense material in distal small bowel (arrow), prox
extravasation into colonic diverticulum (solid arrow). Note the surgical staple line
of bleeding. (C)Superselective distal middle colic arteriogram via a microcathete
was facilitated by prior CT angiography. This vessel was then embolized (imagebe reasonable to manage expectantly without angiog-
raphy or surgery, although this has not been proven. For
lower-GI bleeding, if there is sufficient time for bowel
preparation and experienced endoscopists available,
then colonoscopy should be considered. Alternatively,
CTA could be done and used to guide further
management.
3. The group of patients with massive GI hemorrhage and
hemodynamic instability has not specifically been
studied and, in some of the published studies, were
excluded. In these patients, there is a high likelihood of
active extravasation, and they should likely proceed
directly to angiography unless it is not locally available.
CT should only be considered if it can be done in such
a way as to not delay angiography.Catheter AngiographyCatheter angiography is an attractive diagnostic modality
for evaluation of GI hemorrhage because it is a potentially
diagnostic and therapeutic tool. It is widely quoted that angi-
ography can detect bleeding at rates between 0.5 and 1.0 mL/
min [35,36]. Complications include access-site hematoma orosed with computed tomography (CT) and treated by embolization. (A) Axial
imal to ileocolic anastamosis. (B) Coronal arterial phase CT showing active
(dashed arrow). The CT findings suggest a middle colic branch as the source
r (arrow), confirming active extravasation. Rapid selection of bleeding artery
s not shown).
Figure 5. Acute intra-abdominal and upper gastrointestinal bleed from gastroduodenal artery (GDA) stump blowout after Whipple’s procedure. The patient
presented with hematemesis and bloody discharge from the Jackson-Pratt (JP) drain. (A) Celiac arteriogram showing active extravasation from GDA stump
(long arrow). Note the right upper quadrant drainage catheter (short arrow) and the JP drain (dashed arrow). (B) Celiac arteriogram after placement of a 7-mm-
diameter stent graft (arrow) shows cessation of hemorrhage.
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induced nephropathy or allergic reaction. Serious complica-
tions are uncommon, occurring in <2% of patients [46].
Angiography is limited, however, by the fact that it requires the
presence of active hemorrhage at the time of study. Angiog-
raphy is further complicated by the fact that 75% of bleeding
ceases spontaneously (Figure 3) and there can be minute-to-
minute changes in bleeding (Figure 1) [47]. The diagnostic
yield of angiography is variable due to these factors. The
sensitivity for a diagnosis of GI bleeding is 42%-86% and the
specificity approaches 100% [48]. One group showed that an
increased shock index (defined as the ratio of heart rate to
systolic blood pressure) increases the likelihood of a positive
angiogram [49]. The yield of angiography may also be
improved by the use of CO2 as a contrast agent [50]. A negative
study requires selective angiography of all 3 mesenteric
vessels, the celiac axis, superior mesenteric artery, and inferior
mesenteric artery.
Some investigators have proposed the use of provocative
angiography to improve the ability to detect and then treat
hemorrhage, especially in the setting of recurrent hemor-
rhage after previously negative angiography and endoscopy
[51,52]. Generally, provocative angiography is accomplished
by selective intra-arterial injection of various agents,
including heparin, thrombolytics (streptokinase, urokinase,
tissue plasminogen activator, or reteplase), and vasodilators
(nitroglycerine, tolazoline, or verapamil). Only a few studies
have examined this approach, and, although the technique is
safe and can induce bleeding in some patients, the studies are
small, and there is no established protocol. Therefore, the
technique has limited applicability to wider practice.
TreatmentEndoscopy and/or ColonoscopyFor upper GI bleeding, endoscopic therapy is highly
successful, with reported success rates of 80%-90% for botharterial bleeding [19] and variceal hemorrhage [53]. For
lower GI bleeding, the rate of successful treatment by
colonoscopy is 8%-37% [16]. Therefore, upper GI bleeding
is primary managed endoscopically with endovascular
techniques reserved for failed endoscopic management. In
the lower GI tract, endovascular management is used after
failed colonoscopy and may be the first line of therapy in
patients with massive GI bleeding and hemodynamic
instability.Endovascular TreatmentEndovascular management of GI hemorrhage was first
described in 1971 and was performed by selective mesenteric
arterial injection of vasopressin [35]. This technique requires
prolonged infusion of vasopressin and intensive monitoring
in an intensive care unit setting. The technique has a high
initial success rate of 60%-100% but is hampered by high
rebleeding rates of 18%-50% [54e57]. In addition, the
technique is contraindicated in patients with severe coronary
artery disease, limb ischemia, severe hypertension, or
arrhythmia [46]. The use of vasopressin has largely been
supplanted by modern embolization techniques.
With advances in catheter technology and the introduction
of microcatheters, selective and superselective embolization
is now the endovascular treatment of choice for GI hemor-
rhage. A wide variety of embolic materials are available,
including autologous blood clot, gelatin sponge, small
particles of polyvinyl alcohol or resin, and coils (both mac-
rocoils formed of 0.035-inch-diameter metal or microcoils
formed of 0.018-inch-diameter metal) and liquid embolic
agents, such as n-butyl cyanoacrylate glue [58] or liquid
polyvinyl alcohol copolymer [59]. Coils are often the
preferred agent due to the wide range of lengths and diam-
eters available and to the ability to very precisely deploy
them. Particulate agents carry a risk of distal embolization or
nontarget embolization. Liquid embolic agents can be diffi-
cult to control and should only be used by experienced
Figure 6. Transjugular portosystemic shunt (TIPSS) insertion for refractory variceal hemorrhage after 2 attempts at endoscopic hemostasis. (A) Axial venous
phase computed tomography shows large volume ascites (white arrow) and large varices at the gastroesophageal junction (black arrow). (B) Direct portography
via a percutaneous catheter (arrow) inserted via the left portal vein. This catheter allows for portography, direct portal pressure measurement and acts as a target
for the transhepatic puncture needle. (C) A transhepatic catheter has been advanced from the right hepatic vein into the upper superior mesenteric vein (SMV).
Note the filling defect (arrow) indicating thrombus in the proximal SMV. (D) After TIPSS insertion, venography shows preferential filling of the TIPSS and
appropriate decreased filling of the peripheral portal veins. Note the different appearance of the uncovered portion of the stent in the portal vein (black arrow)
and the covered portion of the stent in the hepatic parenchymal tract (white arrow).
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is from 70%-90% for lower GI bleeding [60] and from 66%-
82% for upper GI bleeding, with recurrence rates of <15%
[61]. Recurrent hemorrhage can be treated by repeated
embolization if necessary.
The approach to embolization depends on the site and
nature of the hemorrhage. Ideally, superselective emboliza-
tion of an actively bleeding vessel is performed with
a microcoil after cannulating the bleeding artery with
a microcatheter (Figures 1 and 4), which is particularly
important in the lower-GI tract where there are fewer
collaterals and a higher risk of ischemia with less-selective
embolization [37,62,63]. In the upper GI tract, nonselective
embolization of the gastroduodenal artery may be performed
in the setting of diffuse bleeding or a large pseudoaneurysm,
or an inability to access an actively bleeding artery. Because
of the extensive collateral arterial network in the upper GI
tract, ischemic complications are rare. Another consequence
of these collaterals is the need to embolize both proximal and
distal to an aneurysm or bleeding vessel to prevent retrograde
perfusion from a collateral vessel, which is colloquiallyknown as embolizing both the ‘‘front door’’ and the ‘‘back
door,’’ which is particularly important in embolization of the
gastroduodenal artery or the inferior and superior
pancreaticoduodenal arteries. It is critical to perform both
celiac and superior mesenteric artery arteriography after
completing embolization in the gastroduodenal artery or the
pancreaticoduodenal branches to rule of persistent bleeding
via collaterals.
Occasionally, in the upper GI tract, in the setting of
a recent positive endoscopy in which bleeding could not be
stopped by endoscopic techniques, active extravasation
cannot be identified. In this setting, it is acceptable to
perform empiric embolization of either the left gastric artery
or the gastroduodenal artery. The appropriate artery can be
chosen based on the placement of an endoscopic clip at the
site of bleeding. Alternatively, empiric embolization can be
based on the described location of bleeding, with antral and
duodenal lesions treated by empiric embolization of the
gastroduodenal artery and lesser curvature or fundal lesions
being treated with left gastric artery embolization. This
approach has been shown to stop bleeding and to reduce
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effective as embolization of an actively bleeding vessel
[65,66], particularly in patients with gastric sources of
bleeding [67].
GI hemorrhage may also be due to arterioenteric fistula or
postsurgical pseudoaneurysm or arterial stump ‘‘blow-out.’’
These etiologies of hemorrhage can also be treated with
endovascular techniques [68]. In the setting of a noncritical
parent artery, hemostasis can be obtained by embolization of
the parent artery [69]. If the parent vessel is critical, then
hemostasis can be obtained by placement of a stent graft [70]
(Figure 5). There is a high infection rate in these stent grafts,
and surgery is often needed at a later date to definitively
manage this difficult problem.
For patients with variceal hemorrhage, who have failed
endoscopic therapy, endovascular treatment is accomplished
by insertion of a transjugular intrahepatic portosystemic
shunt [71,72]. In this method, a tract is created between
a hepatic vein (usually the right) and a portal vein (usually
the right). This tract is then lined with a specially designed
partially covered and partially uncovered stent (Figure 6) and
is dilated with an angioplasty balloon with the goal of
reducing the portosystemic gradient to <12 mm Hg. This
technique has a high technical success rate and low
rebleeding rate, particularly for esophageal varices [73]. This
purpose-built stent graft has 89% primary patency at 12
months, improved over noncovered stents and nondedicated
stent grafts [74]. Early use of a transjugular intrahepatic
portosystemic shunt is associated with improved survival
over best medical therapy [71].
Gastric varices can also be treated by balloon-occluded
retrograde transvenous obliteration [75], which is a rela-
tively new technique with a high technical and clinical
success rate in the acute setting; it is also effective in
reducing rebleeding rates [76,77]. Balloon-occluded retro-
grade transvenous obliteration is performed via a retrograde
approach from the common femoral vein. An occlusion
balloon is placed into the left adrenal vein, and the varices
can then be embolized with a variety of agents, most
commonly a sclerosant such as sodium tetradecyl sulfate or
n-butyl cyanoacrylate glue.SurgeryIn the acute setting, most investigators consider less-
invasive treatment with endoscopy or transcatheter tech-
niques preferable to surgical treatment, which has high
morbidity andmortality [78]. Surgery is reserved for intractable
bleeding after failed attempts at endoscopic and endovascular
therapy. When surgery is performed, a directed segmental
resection is the preferred treatment. This approach has a lower
morbidity and mortality rate with a low rate of rebleeding [48].
Conclusion
Radiologists have an extremely important role in the
diagnosis and treatment of patients with acute GIhemorrhage. Although this role is somewhat secondary in
patients with upper GI bleeding because of the diagnostic
and therapeutic success of endoscopy, imaging and endo-
vascular therapy has a more primary role in the management
of lower GI bleeding. With the results of recent prospective
studies and meta-analyses, CT can be recommended as the
initial imaging modality in hemodynamically stable patients
with GI hemorrhage. For those who are unstable, catheter
angiography should be the modality of choice because it
allows for simultaneous diagnosis and treatment. If endo-
vascular management is appropriate, then the best practice,
when possible, is superselective embolization of the bleeding
vessel.
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